The weekly litigation news digest is live. Subscribe now

Liposomes With Lipids Having An Advantageous Pka- Value For Rna Delivery

Patent No. EP2590626 (titled "Liposomes With Lipids Having An Advantageous Pka- Value For Rna Delivery") was filed by Glaxosmithkline on Jul 6, 2011. The application was issued on Oct 28, 2015.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_616/2025Nov 6, 2025GlaxosmithklineInfringement
UPC_CFI_620/2025Jul 3, 2025GlaxosmithklineInfringement

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DENNEMEYER & ASSOCIATESJul 28, 2016SYNERGY GROUP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2590626

GLAXOSMITHKLINE
Application Number
EP11736500A
Filing Date
Jul 6, 2011
Status
Granted And Under Opposition
Apr 12, 2018
Publication Date
Oct 28, 2015